[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-367875-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-367875-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","the-absence-of-peroxiredoxin-1-in-human-pancreatic-ductal-adenocarcinoma-pdac-markedly-reduces-cell-survival-and-tumor-growth-when-coupled-with-the-inhibition-of-ref-1-redox-signaling","The absence of Peroxiredoxin-1 in human pancreatic ductal adenocarcinoma (PDAC) markedly reduces cell survival and tumor growth when coupled with the inhibition of Ref-1 redox signaling","","Pancreatic ductal adenocarcinoma (PDAC) remains highly resistant to therapy, surviving despite hypoxia, oxidative stress, and nutrient deprivation. Redox effector factor-1 (Ref-1) regulates oncogenic transcription factors and is controlled by peroxiredoxins (PRDX). PRDX1 loss sensitized PDAC to Ref-1 redox inhibition by APX2014 without impairing Ref-1 DNA repair. Combination therapy reduced NF-κB and HIF-1α activity, tumor growth, and improved animal survival; patient data showed increased Ref-1 and PRDX1 vs normal tissue.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/the-absence-of-peroxiredoxin-1-in-human-pancreatic-ductal-adenocarcinoma-pdac-markedly-reduces-cell-survival-and-tumor-growth-when-coupled-with-the-inhibition-of-ref-1-redox-signaling/367875/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/the-absence-of-peroxiredoxin-1-in-human-pancreatic-ductal-adenocarcinoma-pdac-markedly-reduces-cell-survival-and-tumor-growth-when-coupled-with-the-inhibition-of-ref-1-redox-signaling/367875.png","ImageObject",300,407,{"name":42,"@type":43},"Aldword","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-01","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the study’s main finding about PRDX1 and PDAC sensitivity to APX2014?","Question",{"text":63,"@type":64},"Silencing or CRISPR/Cas9 knockout of PRDX1 sensitized PDAC cell lines to APX2014 in vitro and in vivo, without affecting Ref-1’s DNA repair function.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Does inhibiting Ref-1 redox signaling interfere with Ref-1’s DNA repair role?",{"text":68,"@type":64},"No. APX2014 inhibition targeted Ref-1 redox activity while sparing its DNA repair function (apurinic/apyrimidinic endonuclease).",{"name":70,"@type":61,"acceptedAnswer":71},"How does the PRDX1-Ref-1 axis affect downstream pathways and tumor microenvironment interactions?",{"text":72,"@type":64},"PRDX1 loss combined with APX2014 decreased NF-κB and HIF-1α activity and downstream targets, and impaired PRDX1-null tumor growth while reducing CAF viability in 3D co-culture, indicating redox crosstalk within the TME.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},367875,1790214180,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},2336478940917,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","Redox Biology 86 (2025) 103848  \nContents lists available at ScienceDirect  \nRedox Biology  \njournal [homepage:](homepage: www.elsevier.com/locate/redox)[ www.elsevier.com/locate/redox](homepage: www.elsevier.com/locate/redox)  \n| The absence of Peroxiredoxin-1 in human pancreatic ductaladenocarcinoma (PDAC) markedly reduces cell survival and tumor growth when coupled with the inhibition of Ref-1 redox signaling\u003Cbr>Sonia Kirana, Randall S. Wiremana, Jacqueline Peila, Dana K. Mitchell a,\u003Cbr>Elizabeth Sierra Potchananta,b, Ratan Raic, Jonah Z. Vilseckc, Sha Cao d, Sanya Haiatya, Millie M. Georgiadis c, Melissa L. Fishel a,b,c,1, Mark R. Kelley a,b,c,1,* \u003Cbr>a Department of Pediatrics and Herman B Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN, USA b Indiana University Simon Comprehensive Cancer Center, Indiana University School of Medicine, Indianapolis, IN, USA\u003Cbr>c Indiana University School of Medicine, Department of Biochemistry, Molecular Biology and Pharmacology, Indianapolis, IN, USA d Department of Biomedical Engineering, Oregon Health & Science University, USA |  |  |\n| --- | --- | --- |\n| A R T I C L E I N F O |  | A B S T R A C T |\n| Keywords: Pancreatic cancer Redox factor-1\u003Cbr>Peroxiredoxin\u003Cbr>Tumor microenvironment HIF-1α\u003Cbr>NF-κB |  | Pancreatic ductal adenocarcinoma (PDAC) remains highly resistant to therapy, surviving despite hypoxia, oxidative stress, and nutrient deprivation. Redox effector factor-1 (Ref-1) regulates several oncogenic transcription factors (TFs) and is controlled by peroxiredoxins (PRDX). We investigated how Ref-1 inhibition by APX2014, combined with PRDX expression, affects pancreatic cancer cells from multiple patient lines. Silencing or CRISPR/Cas9 knockout of PRDX1—but not PRDX2-6—sensitized PDAC cell lines to APX2014 both in vitro and in vivo without affecting Ref-1’s DNA repair function of apurinic/apyrimidinic endonuclease. The combination of PRDX1 loss and APX2014 treatment increased apoptosis and decreased TF activity (NF-κB, HIF-1α) and their downstream targets, TNFAIP2, Survivin, and CA9. A 3D co-culture with PRDX1-null tumor spheroids and cancerassociated fibroblasts (CAFs) showed that (i) Ref-1 inhibition impaired PRDX1-null tumor growth, and (ii) PRDX1 loss reduced CAF viability, highlighting redox crosstalk within the tumor microenvironment (TME). In a PDAC xenograft model, PRDX1-knockout tumors treated with APX2014 had smaller volumes, lighter weights, lower Ref-1, and decreased Ki-67, with improved animal survival. Patient microarrays indicated increased Ref-1 and PRDX1 levels versus normal tissue, emphasizing their clinical relevance. Overall, these data identify PRDX1 as a key factor for PDAC’s susceptibility to Ref-1 blockade, suggesting dual targeting could disrupt TME redox signaling, limit tumor progression, and improve APX therapy. These findings support dual targeting of Ref-1 and PRDX1 as a promising therapeutic approach in PDAC and other redox-driven cancers. |\n\n1. Introduction  \nPancreatic ductal adenocarcinoma (PDAC) is highly heterogeneous, genetically unstable, and intrinsically resistant to therapy. Redox effector factor-1 (Ref-1) is highly elevated in PDAC and coordinates several oncogenic transcription factors (TFs) such as HIF-1α, NF-κB, STAT3, and AP-1, thereby driving multiple cancer pathways [1–6]. Ref-1 serves another significant role beyond its redox regulation of TFs; it also acts as a DNA repair endonuclease, with both functions entirely separable. Since Ref-1’s redox and DNA-repair domains are distinct, APX  \ninhibitors selectively inhibit only the redox activity [7–9] while sparing the repair function [2,10–13]. Studies utilizing HSQC NMR experiments have previously mapped the binding pocket for Ref-1 specific redox inhibitors, APX3330 and APX2009 [14,15], and the latest APX2014 binding data are presented here.  \nThe TME of PDAC is a complex and dynamic network of cell types that exhibit plasticity and con","cbCaiqeQJGrvEhAN","https://ap.wps.com/l/cbCaiqeQJGrvEhAN","pdf",12603352,15,"English","# Introduction\n## Ref-1 redox regulation and DNA repair independence\n## PDAC tumor microenvironment, CAFs, and oxidative stress\n## Study rationale: Ref-1 and PRDX1 in tumor-stroma crosstalk","[{\"question\":\"What is the study’s main finding about PRDX1 and PDAC sensitivity to APX2014?\",\"answer\":\"Silencing or CRISPR/Cas9 knockout of PRDX1 sensitized PDAC cell lines to APX2014 in vitro and in vivo, without affecting Ref-1’s DNA repair function.\"},{\"question\":\"Does inhibiting Ref-1 redox signaling interfere with Ref-1’s DNA repair role?\",\"answer\":\"No. APX2014 inhibition targeted Ref-1 redox activity while sparing its DNA repair function (apurinic/apyrimidinic endonuclease).\"},{\"question\":\"How does the PRDX1-Ref-1 axis affect downstream pathways and tumor microenvironment interactions?\",\"answer\":\"PRDX1 loss combined with APX2014 decreased NF-κB and HIF-1α activity and downstream targets, and impaired PRDX1-null tumor growth while reducing CAF viability in 3D co-culture, indicating redox crosstalk within the TME.\"}]","The absence of Peroxiredoxin-1 in human pancreatic ductal adenocarcinoma (PDAC) markedly reduces cell survival and tumor growth when coupled with the inhibition of Ref-1 redox signaling | PDF",1790173117,38,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6ea121f8a3b9e44a601f9f2211994811.webp",983,1310,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c68b4acfd0f3cf73ef6c773af65e4891.webp",982,1309,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bab6adb1168c9e3367094d405ee344c6.webp",981,1308,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c0547b61a29c43dc39bca958d2cbb7cc.webp",980,1306]